3rd Quarter - Report

FORBES-TATE for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade related issues.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax related issues.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Intellectual Property and Process Patent Issues.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to the Vice President's National Cancer Moonshot Initiative.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement; issues relating to Prescription Drug User Fee Act and ASP +6 and Part B Demo; issues related to comparative effectiveness and follow-on biologics; issues related to FDA repeal of Avastin; issues related to coverage of Lucentis and Avastin; issues related to 340B; issues related to the 21st Century Cures Act, H.R. 6.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.